eISSN: 3023-6940
The New Journal of Urology
  • Home
  • Evaluation of overactive bladder symptoms with OAB-V8 form in obese patients

Article Tools

Related Subjects

E-SUBMISSION

Original Research

Evaluation of overactive bladder symptoms with OAB-V8 form in obese patients


1 Tepecik Eğitim ve Araştırma Hastanesi Aile Hekimliği Kliniği, Obezite Polikliniği, İzmir

2  Katip Çelebi Üniversitesi Atatürk Eğitim ve Araştırma Hastanesi Üroloji Kliniği, İzmir

3 Aile Hekimliği Kliniği Eğitim ve İdari Sorumlusu; Tepecik Eğitim ve Araştırma Hastanesi Aile Hekimliği Kliniği, İzmir


DOI :
New J Urol. 2013; 8 (3): 6-11
Abstract

Abstract

Sixty six years-old male patient, who un-derwent transurethral resection of bladder tumor and consequent intravesical Mitomy-cin-C chemotherapy, developed interstitial pneumonia. Forty mg intravesical Mitomy-cin-C was instillated weekly. Four days after the third instillation, the patient presented to emergency service with the complaint of progressive dyspnea. High resolution tho-rax tomography demonstrated ground glass opacity in the right upper and bilateral lower lobes, bilateral pleural effusion and interlob-ular septal thickening. Infection and collagen vascular disease were excluded. Symptomatic and radiological improvement achieved with discontinuation of intravesical Mitomycin-C and initiation of prednisolone treatment. In-travesical Mitomycin-C may cause rare sys-temic side effects like interstitial pneumonia. Keywords: Mitomycin; Lung Diseases, Interstitial; Pneumonia; Urinary Bladder Neoplasms

Abstract

Sixty six years-old male patient, who un-derwent transurethral resection of bladder tumor and consequent intravesical Mitomy-cin-C chemotherapy, developed interstitial pneumonia. Forty mg intravesical Mitomy-cin-C was instillated weekly. Four days after the third instillation, the patient presented to emergency service with the complaint of progressive dyspnea. High resolution tho-rax tomography demonstrated ground glass opacity in the right upper and bilateral lower lobes, bilateral pleural effusion and interlob-ular septal thickening. Infection and collagen vascular disease were excluded. Symptomatic and radiological improvement achieved with discontinuation of intravesical Mitomycin-C and initiation of prednisolone treatment. In-travesical Mitomycin-C may cause rare sys-temic side effects like interstitial pneumonia. Keywords: Mitomycin; Lung Diseases, Interstitial; Pneumonia; Urinary Bladder Neoplasms

Creative Commons

LİMRADIGITAL